IDG-Accel China Growth Fund GP III Associates Ltd. is 10% Owner at CASI Pharmaceuticals, Inc. (CASI). They have made 2 open-market trades across 1 company since 2013, most recently 2018-03-21.
CIK 0001564281
2 open-market purchases totalling $24.7M since 2013, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CASI | 9,126,375 | $1.9M |
Shares reported on the most recent Form 4, priced at the 2018-03-23 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.